trial

The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial

NCTId NCT02453217
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 144 (estimated)
Sponsored by Wai-Tong Chien
Primary completion 2018-11-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
144 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2016-03-31
Primary completion
2018-11-30
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Chinese CHIP

Sponsors

Wai-Tong ChienLead Sponsor
Castle Peak HospitalCollaborator

Investigators

2
Daniel T Bressington, PhDPrincipal Investigator
Wai Tong Chien, PhDStudy Director

Sites

0 total

Facts & assertions

4 sourced
Enrollment
144
Phase
NA
Primary Completion Date
2018-11-30
Status
COMPLETED
relationships
The graph out of here
drug
Chinese CHIP
drug
lead_sponsor
Wai-Tong Chien
company
collaborator
Castle Peak Hospital
company
indication
Bipolar Disorder
indication
Severe Mental Illness
indication
Schizoaffective Disorder
indication
investigator
Daniel T Bressington, PhD
person
Wai Tong Chien, PhD
person